Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Epilepsy Research
|
April 15, 2014
Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment
Prasarn Manitpisitkul, Christopher R Curtin, Kevin Shalayda, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
January 1, 2008
Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension
Andreas Tzimos, Viktor Samokhvalov, Michelle Kramer, et al.
Biological Psychiatry
|
July 3, 2007
Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study
Stephen R Marder, Michelle Kramer, Lisa Ford, et al.
Advances in Clinical Chemistry
|
March 26, 2022
Clinical metabolomics for inborn errors of metabolism
Lisa Ford, Matthew Mitchell, Jacob Wulff, et al.
Pediatric Neurology
|
February 18, 2010
Cognitive effects of topiramate in migraine patients aged 12 through 17 years
Gahan J Pandina, Seth Ness, Elena Polverejan, et al.
Epilepsia
|
November 1, 2025
A randomized, double-blind, placebo-controlled, time-to-event study of the efficacy and safety of JNJ-40411813 in combination with levetiracetam or brivaracetam in patients with focal onset seizures
Jacqueline French, Magdalena Bosak, Wesley T Kerr, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Age-Stratified Prevalence of Mild Cognitive Impairment and Dementia in European Populations: A Systematic Review
Myriam Alexander, Gayan Perera, Lisa Ford, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 23, 2021
The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial
Michael Davidson, Linda Levi, Jinyoung Park, et al.
Journal of Clinical Psychopharmacology
|
September 9, 2024
Lack of Efficacy of JNJ-18038683 on Cognitive Impairment in Patients With Stable Bipolar Disorder
Mahdi Arshadi, Ahmed Z Elmaadawi, Suhayl Nasr, et al.
Plos One
|
April 8, 2021
Global biochemical analysis of plasma, serum and whole blood collected using various anticoagulant additives
Adam D Kennedy, Lisa Ford, Bryan Wittmann, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Epilepsy Research
|
April 15, 2014
Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment
Prasarn Manitpisitkul, Christopher R Curtin, Kevin Shalayda, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
January 1, 2008
Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension
Andreas Tzimos, Viktor Samokhvalov, Michelle Kramer, et al.
Biological Psychiatry
|
July 3, 2007
Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study
Stephen R Marder, Michelle Kramer, Lisa Ford, et al.
Advances in Clinical Chemistry
|
March 26, 2022
Clinical metabolomics for inborn errors of metabolism
Lisa Ford, Matthew Mitchell, Jacob Wulff, et al.
Pediatric Neurology
|
February 18, 2010
Cognitive effects of topiramate in migraine patients aged 12 through 17 years
Gahan J Pandina, Seth Ness, Elena Polverejan, et al.
Epilepsia
|
November 1, 2025
A randomized, double-blind, placebo-controlled, time-to-event study of the efficacy and safety of JNJ-40411813 in combination with levetiracetam or brivaracetam in patients with focal onset seizures
Jacqueline French, Magdalena Bosak, Wesley T Kerr, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Age-Stratified Prevalence of Mild Cognitive Impairment and Dementia in European Populations: A Systematic Review
Myriam Alexander, Gayan Perera, Lisa Ford, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 23, 2021
The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial
Michael Davidson, Linda Levi, Jinyoung Park, et al.
Journal of Clinical Psychopharmacology
|
September 9, 2024
Lack of Efficacy of JNJ-18038683 on Cognitive Impairment in Patients With Stable Bipolar Disorder
Mahdi Arshadi, Ahmed Z Elmaadawi, Suhayl Nasr, et al.
Plos One
|
April 8, 2021
Global biochemical analysis of plasma, serum and whole blood collected using various anticoagulant additives
Adam D Kennedy, Lisa Ford, Bryan Wittmann, et al.
Page
of 5